194 related articles for article (PubMed ID: 19671143)
1. Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population.
Siedlinski M; Postma DS; Boer JM; van der Steege G; Schouten JP; Smit HA; Boezen HM
Respir Res; 2009 Aug; 10(1):73. PubMed ID: 19671143
[TBL] [Abstract][Full Text] [Related]
2. NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease.
Sandford AJ; Malhotra D; Boezen HM; Siedlinski M; Postma DS; Wong V; Akhabir L; He JQ; Connett JE; Anthonisen NR; Paré PD; Biswal S
Physiol Genomics; 2012 Aug; 44(15):754-63. PubMed ID: 22693272
[TBL] [Abstract][Full Text] [Related]
3. NFE2L2 polymorphisms, mortality, and metabolism in the general population.
Figarska SM; Vonk JM; Boezen HM
Physiol Genomics; 2014 Jun; 46(12):411-7. PubMed ID: 24790085
[TBL] [Abstract][Full Text] [Related]
4. Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy.
Liu Z; Yin X; Liu L; Tao H; Zhou H; Ma G; Cui L; Li Y; Zhang S; Xu Z; Yao L; Cai Z; Zhao B; Li K
Gene; 2015 Oct; 571(2):231-6. PubMed ID: 26149655
[TBL] [Abstract][Full Text] [Related]
5. Associations of the NRF2/KEAP1 pathway and antioxidant defense gene polymorphisms with chronic obstructive pulmonary disease.
Korytina GF; Akhmadishina LZ; Aznabaeva YG; Kochetova OV; Zagidullin NS; Kzhyshkowska JG; Zagidullin SZ; Viktorova TV
Gene; 2019 Apr; 692():102-112. PubMed ID: 30641209
[TBL] [Abstract][Full Text] [Related]
6. Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis.
Bergström P; von Otter M; Nilsson S; Nilsson AC; Nilsson M; Andersen PM; Hammarsten O; Zetterberg H
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):130-7. PubMed ID: 24102512
[TBL] [Abstract][Full Text] [Related]
7. ABCC1 polymorphisms contribute to level and decline of lung function in two population-based cohorts.
Siedlinski M; Boezen HM; Boer JM; Smit HA; Postma DS
Pharmacogenet Genomics; 2009 Sep; 19(9):675-84. PubMed ID: 19687781
[TBL] [Abstract][Full Text] [Related]
8. KEAP1 polymorphisms and neurodevelopmental outcomes in children with exposure to prenatal MeHg from the Seychelles Child Development Study Nutrition Cohort 2.
de Paula HK; Love TM; Pineda D; Watson GE; Thurston SW; Yeates AJ; Mulhern MS; McSorley EM; Strain JJ; Shamlaye CF; Myers GJ; Rand MD; van Wijngaarden E; Broberg K
Neurotoxicology; 2023 Dec; 99():177-183. PubMed ID: 37858899
[TBL] [Abstract][Full Text] [Related]
9. KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes.
Hartikainen JM; Tengström M; Winqvist R; Jukkola-Vuorinen A; Pylkäs K; Kosma VM; Soini Y; Mannermaa A
Clin Cancer Res; 2015 Apr; 21(7):1591-601. PubMed ID: 25589623
[TBL] [Abstract][Full Text] [Related]
10. Decorin and TGF-beta1 polymorphisms and development of COPD in a general population.
van Diemen CC; Postma DS; Vonk JM; Bruinenberg M; Nolte IM; Boezen HM
Respir Res; 2006 Jun; 7(1):89. PubMed ID: 16780585
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.
Goeman F; De Nicola F; Scalera S; Sperati F; Gallo E; Ciuffreda L; Pallocca M; Pizzuti L; Krasniqi E; Barchiesi G; Vici P; Barba M; Buglioni S; Casini B; Visca P; Pescarmona E; Mazzotta M; De Maria R; Fanciulli M; Ciliberto G; Maugeri-Saccà M
J Thorac Oncol; 2019 Nov; 14(11):1924-1934. PubMed ID: 31323387
[TBL] [Abstract][Full Text] [Related]
12. Genetic variations and haplotype structures of transcriptional factor Nrf2 and its cytosolic reservoir protein Keap1 in Japanese.
Fukushima-Uesaka H; Saito Y; Maekawa K; Kamatani N; Kajio H; Kuzuya N; Noda M; Yasuda K; Sawada J
Drug Metab Pharmacokinet; 2007 Jun; 22(3):212-9. PubMed ID: 17603223
[TBL] [Abstract][Full Text] [Related]
13. Impact on the Clinical Evolution of Patients with COVID-19 Pneumonia and the Participation of the
Soto ME; Fuentevilla-Álvarez G; Palacios-Chavarría A; Vázquez RRV; Herrera-Bello H; Moreno-Castañeda L; Torres-Paz YE; González-Moyotl NJ; Pérez-Torres I; Aisa-Alvarez A; Manzano-Pech L; Pérez-Torres I; Huesca-Gómez C; Gamboa R
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613859
[TBL] [Abstract][Full Text] [Related]
14. Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
von Otter M; Landgren S; Nilsson S; Celojevic D; Bergström P; Håkansson A; Nissbrandt H; Drozdzik M; Bialecka M; Kurzawski M; Blennow K; Nilsson M; Hammarsten O; Zetterberg H
BMC Med Genet; 2010 Mar; 11():36. PubMed ID: 20196834
[TBL] [Abstract][Full Text] [Related]
15. Limited overlap in significant hits between genome-wide association studies on two airflow obstruction definitions in the same population.
van der Plaat DA; Vonk JM; Lahousse L; de Jong K; Faiz A; Nedeljkovic I; Amin N; van Diemen CC; Brusselle GG; Bossé Y; Brandsma CA; Hao K; Paré PD; van Duijn CM; Postma DS; Boezen HM
BMC Pulm Med; 2019 Mar; 19(1):58. PubMed ID: 30845926
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts.
van Diemen CC; Postma DS; Siedlinski M; Blokstra A; Smit HA; Boezen HM
Respir Res; 2011 Apr; 12(1):57. PubMed ID: 21524282
[TBL] [Abstract][Full Text] [Related]
17. Dietary factors and lung function in the general population: wine and resveratrol intake.
Siedlinski M; Boer JM; Smit HA; Postma DS; Boezen HM
Eur Respir J; 2012 Feb; 39(2):385-91. PubMed ID: 21852339
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Pathological Characteristics of
Frank R; Scheffler M; Merkelbach-Bruse S; Ihle MA; Kron A; Rauer M; Ueckeroth F; König K; Michels S; Fischer R; Eisert A; Fassunke J; Heydt C; Serke M; Ko YD; Gerigk U; Geist T; Kaminsky B; Heukamp LC; Clement-Ziza M; Büttner R; Wolf J
Clin Cancer Res; 2018 Jul; 24(13):3087-3096. PubMed ID: 29615460
[No Abstract] [Full Text] [Related]
19. Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study.
Imboden M; Downs SH; Senn O; Matyas G; Brändli O; Russi EW; Schindler C; Ackermann-Liebrich U; Berger W; Probst-Hensch NM;
Respir Res; 2007 Jan; 8(1):2. PubMed ID: 17217536
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in signal transducer and activator of transcription 3 and lung function in asthma.
Litonjua AA; Tantisira KG; Lake S; Lazarus R; Richter BG; Gabriel S; Silverman ES; Weiss ST
Respir Res; 2005 Jun; 6(1):52. PubMed ID: 15935090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
